Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516291-16-00

Acronym

ASTX727-17

Enrollment

Registered

2024-09-09

Start date

2021-10-26

Completion date

Unknown

Last updated

2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS), or solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Poland, Romania, Slovakia, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026